Clinical applications of fibroblast activation protein‐targeted theranostics in oncologic and nononcologic disease: Current status and future directions

Abstract Quinoline‐based fibroblast activation protein (FAP) inhibitor (FAPI)‐based positron emission tomography (PET) imaging and radioligand therapy (RLT) are being investigated for use in a wide variety of diseases, and recent results have been promising. This review summarizes the current status...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hao Fu, Wei Guo, Jingxiong Huang, Hua Wu, Haojun Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-12-01
Colecção:	iRADIOLOGY
Assuntos:	FAPI‐PET FAP‐targeted radioligand therapy FAP‐targeted theranostics fibroblast activation protein radiopharmaceuticals
Acesso em linha:	https://doi.org/10.1002/ird3.46
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!